USP18 and acute kidney injury: In a mouse model of virus-induced AKI, USP18 deficiency exacerbated kidney injury through enhanced type I interferon responses, suggesting that USP18 augmentation may represent a potential therapeutic strategy for virus-associated AKI [106,122].